Business
from24/7 Wall St.
13 hours agoThis Cheap International ETF Does One Job Very Well
IDEV provides broad, low-fee exposure to developed non-U.S. stocks, diversifying beyond a U.S.-centric total market fund with stable, non-leveraged holdings.
BGF has reported a strong year of investment and exit activity in 2025, underpinned by landmark portfolio realisations, robust trading performance and continued backing for founders across the UK and Ireland. The growth capital investor returned more than £600 million during the year, delivering a money multiple of over 2x, and paid a £75 million dividend to shareholders. The performance was driven by a series of high-profile exits, led by the sale of OrganOx, which generated BGF's largest-ever return.